IPO Update: What A Difference A (Pandemic) Year Makes

COVID-19 Paralyzed Market In Q1 2020 But Fortunes Reversed In 2021

IPO (Initial Public Offering) letters hanging from strings
32 biopharma companies went public in the US in Q1, raising $5.2bn and generating an 11% average return • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Financing

More from Business